{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:30:19Z","timestamp":1747182619525,"version":"3.40.5"},"reference-count":12,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Cancer"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We describe a case of diabetic ketoacidosis (DKA) shortly after the SARS\u2010CoV\u20102 (COVID\u201019) vaccination in a 65\u2010year\u2010old woman with non\u2013small\u2010cell lung cancer under a combination treatment of programmed cell death protein 1 (PD\u20101) and cytotoxic T\u2010lymphocyte\u2010associated protein 4 (CTLA\u20104) inhibitors. She had no history of diabetic mellitus. A few days after the second shot of COVID\u201019 vaccination, she developed DKA. We speculate that the immune\u2010related adverse event and immunogenicity of vaccination synergistically induced DKA.<\/jats:p>","DOI":"10.1111\/1759-7714.14352","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T08:05:23Z","timestamp":1644912323000},"page":"1220-1223","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diabetic ketoacidosis shortly after <scp>COVID<\/scp>\u201019 vaccination in a non\u2013small\u2010cell lung cancer patient receiving combination of <scp>PD<\/scp>\u20101 and <scp>CTLA<\/scp>\u20104 inhibitors: A case report"],"prefix":"10.1111","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-7904","authenticated-orcid":false,"given":"Tomonori","family":"Makiguchi","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine Hirosaki University Graduate School of Medicine  Hirosaki Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Hirosaki University Graduate School of Medicine  Hirosaki Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-0210","authenticated-orcid":false,"given":"Hisashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Hirosaki University Graduate School of Medicine  Hirosaki Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kageaki","family":"Taima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Hirosaki University Graduate School of Medicine  Hirosaki Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Takayasu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Hirosaki University Graduate School of Medicine  Hirosaki Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadatomo","family":"Tasaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Hirosaki University Graduate School of Medicine  Hirosaki Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00155-8"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.07.017"},{"key":"e_1_2_8_6_1","unstructured":"https:\/\/news.bms.com\/news\/details\/2021\/Four-Year-Data-from-Phase-3-CheckMate--227-Trial-Show-Durable-Long-Term-Survival-with-Opdivonivolumab-Plus-Yervoy-ipilimumab-in-Patients-with-Non-Small-Cell-Lung-Cancer-with-PD-L1-Expression-1\/default.aspx"},{"issue":"5","key":"e_1_2_8_7_1","first-page":"1","article-title":"Immune\u2010mediated disease flares or new\u2010onset disease in 27 subjects following mRNA\/DNA SARS\u2010CoV\u20102 vaccination","volume":"9","author":"Watad A","year":"2021","journal-title":"Vaccine"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab141"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.02.003"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0235"},{"issue":"40","key":"e_1_2_8_11_1","first-page":"1","article-title":"Influenza vaccination of cancer patients during PD\u20101 blockade induces serological protection but may raise the risk for immune\u2010related adverse events","volume":"6","author":"L\u00e4ubli H","year":"2018","journal-title":"J Immunother Cancer"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4321"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201529"}],"container-title":["Thoracic Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.14352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1759-7714.14352","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.14352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T18:51:35Z","timestamp":1692989495000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1759-7714.14352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/1759-7714.14352"],"URL":"https:\/\/doi.org\/10.1111\/1759-7714.14352","archive":["Portico"],"relation":{},"ISSN":["1759-7706","1759-7714"],"issn-type":[{"type":"print","value":"1759-7706"},{"type":"electronic","value":"1759-7714"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"2021-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}